Crinetics Pharmaceuticals, Inc. - COMMON STOCK (CRNX)
CUSIP: 22663K107
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 105,000,216
- Total 13F shares
- 111,610,559
- Share change
- +3,812,778
- Total reported value
- $5,195,621,593
- Put/Call ratio
- 107%
- Price per share
- $46.55
- Number of holders
- 239
- Value change
- +$186,370,978
- Number of buys
- 131
- Number of sells
- 105
Quarterly Holders Quick Answers
What is CUSIP 22663K107?
CUSIP 22663K107 identifies CRNX - Crinetics Pharmaceuticals, Inc. - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 22663K107:
Top shareholders of CRNX - Crinetics Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
13D/G
|
Company |
15%
from 13D/G
|
14,187,498
|
$590,909,308 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.7%
|
9,170,129
|
$381,935,873 | — | 30 Sep 2025 | |
| Farallon Capital Partners, L.P. |
13D/G
|
Dapice Joshua J. |
8.5%
|
8,024,098
|
$373,521,762 | +$111,673,450 | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
8%
|
8,381,991
|
$349,109,926 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
7.2%
|
7,586,597
|
$315,981,777 | — | 30 Sep 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
6.2%
|
6,481,613
|
$269,959,181 | — | 30 Sep 2025 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
5.5%
|
5,770,098
|
$240,324,582 | — | 30 Sep 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
5.1%
|
5,306,248
|
$221,006,000 | — | 30 Sep 2025 | |
| PERCEPTIVE ADVISORS LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
5,321,032
|
$200,336,855 | — | 18 Apr 2022 | |
| EcoR1 Capital, LLC |
13F
|
Company |
4.1%
|
4,288,120
|
$178,600,198 | — | 30 Sep 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3.7%
|
3,858,791
|
$160,695,917 | — | 30 Sep 2025 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
2.4%
|
2,550,774
|
$106,239,737 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
2,278,830
|
$94,926,353 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
2,207,707
|
$91,950,997 | — | 30 Sep 2025 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.9%
|
2,044,734
|
$85,163,170 | — | 30 Sep 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.9%
|
2,003,333
|
$83,438,803 | — | 30 Sep 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
1.6%
|
1,688,611
|
$70,330,648 | — | 30 Sep 2025 | |
| Novo Holdings A/S |
13F
|
Company |
1.5%
|
1,625,000
|
$67,681,250 | — | 30 Sep 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.4%
|
1,465,262
|
$61,028,162 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.2%
|
1,258,722
|
$52,425,771 | — | 30 Sep 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
1.1%
|
1,133,535
|
$47,211,782 | — | 30 Sep 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1%
|
1,099,000
|
$45,773,350 | — | 30 Sep 2025 | |
| First Light Asset Management, LLC |
13F
|
Company |
0.9%
|
941,516
|
$39,214,141 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.84%
|
884,507
|
$36,839,717 | — | 30 Sep 2025 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.84%
|
883,004
|
$36,777,117 | — | 30 Sep 2025 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.83%
|
872,387
|
$36,334,919 | — | 30 Sep 2025 | |
| GW&K Investment Management, LLC |
13F
|
Company |
0.81%
|
850,546
|
$35,425,000 | — | 30 Sep 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.79%
|
834,031
|
$34,738,000 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.77%
|
809,888
|
$33,731,836 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.74%
|
778,652
|
$32,430,856 | — | 30 Sep 2025 | |
| Fisher Asset Management, LLC |
13F
|
Company |
0.72%
|
758,357
|
$31,585,568 | — | 30 Sep 2025 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.71%
|
750,000
|
$31,237,500 | — | 30 Sep 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.71%
|
745,094
|
$31,033,165 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.68%
|
713,130
|
$29,701,865 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.65%
|
682,134
|
$28,410,904 | — | 30 Sep 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.59%
|
614,816
|
$25,607,130 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.57%
|
601,042
|
$25,033,406 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.52%
|
544,754
|
$22,689,004 | — | 30 Sep 2025 | |
| Fiera Capital Corp |
13F
|
Company |
0.41%
|
435,425
|
$18,135,451 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.39%
|
407,722
|
$16,981,622 | — | 30 Sep 2025 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.38%
|
400,000
|
$16,660,000 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.38%
|
399,634
|
$16,644,768 | — | 30 Sep 2025 | |
| Universal- Beteiligungs- und Servicegesellschaft mbH |
13F
|
Individual |
0.37%
|
387,925
|
$16,157,077 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.36%
|
377,802
|
$15,735,454 | — | 30 Sep 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.32%
|
339,949
|
$14,158,876 | — | 30 Sep 2025 | |
| Prosight Management, LP |
13F
|
Company |
0.31%
|
328,684
|
$13,689,689 | — | 30 Sep 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.28%
|
295,008
|
$12,287,083 | — | 30 Sep 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.27%
|
280,000
|
$11,662,000 | — | 30 Sep 2025 | |
| Checkpoint Capital L.P. |
13F
|
Company |
0.25%
|
260,000
|
$10,829,000 | — | 30 Sep 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.25%
|
257,505
|
$10,725,083 | — | 30 Sep 2025 |
Institutional Holders of Crinetics Pharmaceuticals, Inc. - COMMON STOCK (CRNX) as of Q4 2025
As of 31 Dec 2025,
Crinetics Pharmaceuticals, Inc. - COMMON STOCK (CRNX) was held by
239 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
111,610,559 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., FARALLON CAPITAL MANAGEMENT LLC, Driehaus Capital Management LLC, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, EcoR1 Capital, LLC, and Point72 Asset Management, L.P..
This page lists
239
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
225
Q4 2025 holders
239
Holder diff
14
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.